Following is a list of 25 current or former senior executives of independent nonprofit research institutes, ranked by total compensation for the most recent two years such information was available as furnished by Form 990s filed annually by each institution with the Internal Revenue Service and made public through Guidestar.org and Foundation Center. In most cases, the most recent years available were fiscal years ending in 2011 and 2010. In isolated cases, no new Form 990s had been made public since last year.

Unlike the first edition of this list last year, the percent change in annual pay for each executive was listed. Perhaps reflecting continued pressure on the institutions and other nonprofits to account for executive pay, 10 of the top 25 compensated executives listed either received below-inflation-rate raises, or were paid less than the previous year.

However, another 10 executives listed saw double- or triple-digit pay raises, some of which included severance or payments from organizations related to the research institutions. In four cases, double- and triple-digit raises followed a promotion or extra responsibilities added on an interim basis.

Also unlike last year, the list was expanded beyond CEOs to include other senior-level executives, such as executive vice presidents, board chairs, and C-suite officers. The expansion explains why the top 11 highest-paid executives in this year’s list received total pay exceeding $1 million, compared with the top four CEOs in the 2012 list.

Executives on the list come from 13 research institutions. HHMI alone accounted for eight people, followed by Sanford-Burnham, Stowers, and the J. William Gladstone Institutes (two each), and one each for the other institutions. In some cases the listed chief executives have been succeeded by others; such leadership changes are detailed in footnotes. FY denotes fiscal year; CY denotes calendar year.

Notes:1 Succeeded by Larry Corey, MD, as President and Director on January 1, 2011. Dr. Hartwell joined the faculty of Arizona State University, where he established and co-directs the Center for Sustainable Health at ASU's Biodesign Institute; and is ASU's second Virginia G. Piper Chair of Personalized Medicine.2 Because no updated Form 990 has been made public over the past year, the figure is identical to the one found in the GEN List, “20 Top-Salaried Research Institute Leaders,” published September 25, 2012. 3 Year of departure unavailable.4 2011 total compensation Includes $250,000 severance payment.5 Form 990 covers a shorter-than-one-year timeframe to reflect a change of accounting period.6 Served as interim administrative leader after Richard Woychik, Ph.D., stepped down in January 2011 to join the National Institute of Environmental Health Sciences as Deputy Director. A permanent president and CEO, Edison “Ed” Liu, M.D., took office in January 2012. See http://www.jax.org/news/archives/2010/woychik_niehs.html7 Retired as of June 2013, and has since returned to his lab at University of California, San Diego, where he will continue his research on protein tyrosine phosphatases. See: http://www.hhmi.org/news/jack-dixon-retire-hhmi-vice-president-and-chief-scientific-officer8 Includes $41,650 in “estimated other compensation from the organization and related organizations.” Winner of the 2012 Benjamin Franklin Medal in Life Science from the Franklin Institute.9 Named VP for Science Education in September 2010, after serving as an Investigator from 1990–201010 Includes $37,709 in “estimated other compensation from the organization and related organizations.”11 Named EVP and COO as of September 2010, after serving as COO of the Institute’s Janelia Farm Research Campus. See: http://www.hhmi.org/news/cheryl-moore-named-hhmi-s-first-chief-operating-officer12 Has served as President since April 2010, and as interim CEO since January 2013, when John C. Reed, M.D., Ph.D., resigned to accept position as Head of Roche Pharma Research and Early Development, and member of Roche’s Corporate Executive Committee. See: http://beaker.sanfordburnham.org/2013/01/john-reed-resigns-ceo-accepts-roche/13 Compensation comes from “related organizations” rather than directly from the institution, according to Stowers’ Form 990 returns for 2011 and 2010.14 Succeeded by Michael A. Marletta, Ph.D., as President and CEO on January 1, 2012.15 Resigned as CEO in January 2013 to accept position as Head of Roche Pharma Research and Early Development, and member of Roche’s Corporate Executive Committee. His duties have since been assumed on an interim basis by Kristiina Vuori, M.D., Ph.D. See: http://beaker.sanfordburnham.org/2013/01/john-reed-resigns-ceo-accepts-roche/

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

If you have any questions about your subscription, click
hereto email us or call at (914) 740-2189.

You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
more.